Prescription Justice Weekly Media Update

View this email in your browser

Weekly Media Update on Policy and Advocacy
in the U.S. to Bring Down Drug Prices

High Drug Prices Remain a Conundrum, Analysts Say

MedPage Today
April 4, 2017 - The problem of high prescription drug costs has no easy solution, analysts said Tuesday at an event here sponsored by Johns Hopkins University.

"It's a major problem ... and there's no light at end of tunnel," said Joshua Sharfstein, MD, associate dean for practice and training at Johns Hopkins University's Bloomberg School of Public Health in Baltimore.

Democrats Found a Way to Speak Trump's Language in Pharma Debate

Yahoo Finance
April 4, 2017 - A quartet of Democratic members of Congress introduced a bill last week in harmony with President Donald Trump’s campaign promises of lowering prescription drug costs. Entitled the Improving Access to Affordable Prescription Drugs Act, the 128-page bill aims to overhaul what many view as a broken system that has seen bipartisan outrage over skyrocketing prices. A companion bill was also introduced in the Senate.

The Cost of Cancer: New Drugs Show Success at a Steep Price

Reuters
April 3, 2017 - Newer cancer drugs that enlist the body's immune system are improving the odds of survival, but competition between them is not reining in prices that can now top $250,000 a year.

The drugs' success for patients is the result of big bets in cancer therapy made by Bristol-Myers Squibb Co (BMY.N), Merck & Co Inc (MRK.N) and Roche Holding AG (ROG.S), among others in big pharma. The industry's pipeline of cancer drugs expanded by 63 percent between 2005 and 2015, according to the QuintilesIMS Institute, and a good number are reaching the market.

In this Issue:

High Drug Prices Remain a Conundrum, Analysts Say

Democrats Found a Way to Speak Trump's Language in Pharma Debate

The Cost of Cancer: New Drugs Show Success at a Steep Price

About Prescription Justice

Prescription Justice, a 501c4 non-profit organization, brings together doctors, lawyers, public health advocates, and companies dedicated to lowering drug prices in the United States. We advocate on behalf of the millions of Americans who access affordable imported medications and stand against actions by the pharmaceutical industry that mislead and misinform the public.

Forty-five million Americans did not fill a prescription in 2016 due to cost. Millions often choose between food and medicine in the world’s richest country. Forgoing prescribed medication leads to sickness and death, and even larger healthcare costs from hospitalizations when patients stop taking their medications. Prescription Justice is dedicated to ending this crisis of high drug prices.

Prescription Justice received initial funding by PharmacyChecker.com. For more information about Prescription Justice, visit our website.

Forward

This email was sent to <<Email Address>>
why did I get this? unsubscribe from this list update subscription preferences
Prescription Justice · 3309 Robbins Rd, 412 · Springfield, IL 62704 · USA

High Drug Prices Remain a Conundrum, Analysts Say

Democrats Found a Way to Speak Trump's Language in Pharma Debate

The Cost of Cancer: New Drugs Show Success at a Steep Price

April 5, 2017

In this Issue: